|
|
Article: Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income.(Financial report)
- Article from:
- Investment Weekly News
- Article date:
- November 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Matrixx Initiatives, Inc. (NASDAQ:MTXX), an over-the-counter healthcare company that develops and markets Zicam[R] products, announced financial results for its fiscal second quarter and six months ended September 30, 2009. Second quarter revenue decreased 24% to $25.6 million compared to $33.6 million for the comparable quarter in the prior year. The Company reported net income for the quarter of $5.1 million, or $0.55 per diluted share, compared to net income of $8.2 million, or $0.86 per diluted share, for the quarter ended September 30, 2008.
The lower sales in the quarter ended September 30, 2009 versus the prior year is primarily attributable to the loss of ...